Breaks Categories: News

WednesdayDec 16, 2020 3:16 pm

CannabisNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) Commences Trading on the OTCQB Venture Market

Pac Roots (CSE: PACR) (OTCQB: PACRF) (“PacRoots”), dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach, today announced that it has commenced trading in the United States on the OTCQB Venture Market under the symbol "PACRF." The company anticipates that its new U.S. listing will provide greater liquidity and a more seamless trading experience for its U.S. shareholders and potential investors. "With the cannabis industry gaining momentum in the United States, this cross-border listing will increase our visibility and open the doors to new investors as well as enable exciting business opportunities," said Pac Roots president and…

Continue Reading

WednesdayDec 16, 2020 11:40 am

CannabisNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Announces Progress in Commercialization Plan with Initial Product Expected in Q1 2021

Willow Biosciences (TSX: WLLW) (OTCQX: CANSF) has contracted with a leading manufacturer to produce its first cannabinoid, cannabigerol ("CBG"); the first production run is slated for early 2021 and will result in commercial quantities of Willow’s ultra-pure CBG. The product will be manufactured in Europe. In addition, Willow announced plans to run a second 500-litre pilot this month in order to meet demand for customer samples and streamline the production process. These announcements mark significant progress for the company in its strategic commercialization plan. Based on progress so far, the company noted that it anticipates seeing revenue generated from this…

Continue Reading

TuesdayDec 15, 2020 2:36 pm

CannabisNewsBreaks – Way2Grow (‘W2G’) Biopharma Company Announces Entry into Cannabis Productivity, Plans for Psychedelic Research and Development

Way2Grow Nurseries (“Way2Grow” or “W2G”), a privately held biopharma company, today announced its entry into the productivity phase of cannabis cultivation, micropropagation and extraction. The company also announced its preparation of a Health Canada application towards psychedelic research and development for a medicinal mushroom (Psilocybe semilanceata) Dealer Licence and a Section 56 Exemption for use of psilocybin production and extraction for planned preclinical research under scientific purposes, per the Controlled Drugs and Substances Act (the “CDSA”). According to the update, W2G has secured approval for a single-story production facility designed to support tissue culture and micropropagation and to meet organic…

Continue Reading

TuesdayDec 15, 2020 10:52 am

CannabisNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) Notes Appreciation for Health Canada Milestone Special Access Programme

Pure Extracts Technologies (CSE: PULL), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sector, has voiced its support and appreciation for Health Canada’s recently announced Special Access Programme (“SAP”) for psilocybin-assisted psychotherapy inclusion. The government entity recently announced its intent to revise the SAP and other related regulations to allow limited uses of psilocybin-assisted psychotherapeutic treatments. The SAP revision may open the door to new medical applications in the mental health space and support the progress of advanced research initiatives, including ongoing clinical trials evaluating psilocybin-assisted psychotherapy. The proposed SAP update may also positively…

Continue Reading

ThursdayDec 10, 2020 10:12 am

CannabisNewsBreaks – Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) Lays Groundwork for Move into World of Psychedelics

Pure Extracts Technologies (CSE: PULL) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging functional mushroom sector, today announced its engagement of a globally recognized operations, compliance and regulatory consulting firm to advise on the company’s application to Health Canada for a Dealers Licence under the Controlled Drugs and Substances Act (“CDSA”). “Having the support of one of Canada’s premiere consulting companies with subject matter proficiency in cannabis and other regulated consumer product industries assures that we will submit a fully-compliant Dealers Licence application to Health Canada in the shortest time possible,” said Pure Extracts…

Continue Reading

TuesdayDec 08, 2020 12:30 pm

CannabisNewsBreaks – Way2Grow (‘W2G’) Biopharma Company Secures Health Canada Approval for Standard Cultivation, Processing, Medical Sales

Way2Grow Nurseries (“Way2Grow” or “W2G”), a privately owned biopharma company, today announced its receipt of Health Canada’s approval for the standard cultivation, standard processing and sale for medical purposes under the Cannabis Regulations. According to the update, the licenses are effective as of Nov. 20, 2020. Valid for a three-year period, the terms of the licenses include approval of a single-story production facility designed to support micropropagation tissue culture, organic cultivation, processing and medical sales requirements. Phase II plans include expansion of the research laboratory and controlled cultivation rooms, as well as the addition of a medical dispensary. To view…

Continue Reading

TuesdayDec 08, 2020 12:03 pm

CannabisNewsBreaks – Gage Cannabis Co. Executive Chairman Discusses Milestones, Record-Breaking Sales, Near-Term Goals in Audio Interview

Gage Cannabis Co., a leading vertically integrated operator in the cannabis industry, today announced that its Executive Chairman Bruce Linton was featured in an exclusive audio interview with NetworkNewsWire (“NNW”), a financial news and content distribution company and one of 50+ brands in the InvestorBrandNetwork (“IBN”). During the interview, Linton provided an update on the company’s recent milestones, its record-breaking cannabis sales in Michigan, as well as its near-term goals that include an IPO planned for 2021. “We found that Michigan is doing more than $100 million a month in cannabis, so the medical and recreational opportunity is there to…

Continue Reading

TuesdayDec 08, 2020 11:09 am

CannabisNewsBreaks – Pac Roots Cannabis Corp. (CSE: PACR) CEO Discusses Milestones, Focus on Genetics in Exclusive Interview

Pac Roots (CSE: PACR) (“PacRoots”), dedicated to producing premium-quality strains and products by leveraging a genetics-focused approach, today announced that its president and CEO, Patrick Elliott, was featured in an exclusive audio interview with NetworkNewsWire (“NNW”), a financial news and content distribution company and one of 50+ brands in the InvestorBrandNetwork (“IBN”). During the interview, Elliott discussed the company’s devotion to cannabis genetics as well as milestones Pac Roots has achieved since it began trading earlier this year. “The company is built on genetics. We believe genetics are paramount, and we deploy these into our own projects and also lean…

Continue Reading

FridayDec 04, 2020 12:21 pm

CannabisNewsBreaks – Marijuana Company of America, Inc. (MCOA), Cannabis Global (CBGL) Issue Joint Shareholder Letter

Marijuana Company of America (OTCQB: MCOA), based in Escondido, California and focused on cannabidiol (“CBD”) products, together with Cannabis Global Inc. (OTC: CBGL), an innovation-oriented company investing in disruptive cannabis and hemp-related technologies, on Thursday issued a joint letter to shareholders. Recently, the companies entered into an agreement wherein each became the largest shareholder of the other. As a result, CBGL owns 650 million shares of MCOA and MCOA owns just over 7.2 million shares of CBGL. The transaction intends to promote the growing common interests and collaborations between the two pioneering cannabis and CBD operations. The update reads, “Both…

Continue Reading

FridayDec 04, 2020 11:56 am

CannabisNewsBreaks – CannAssist International Corporation’s (CNSC) Reg. A Offering Capital to Boost Continued Brand Expansion, Benchmarks

CannAssist (OTCQB: CNSC), a unique, enhanced cannabidiol (“CBD”) company, recently announced SEC approval of its Reg. A+ Tier 2 Filing as of Oct. 13, 2020, and an opportunity for investors to purchase shares at a set price stated in filing. “CannAssist International is building digital platforms, implementing a Brand PR and Sales/Marketing Campaign, expanding distribution, building inventory and enhancing the Xceptol brand,” said CannAssist’s CEO and Founder Mark Palumbo. “Gaining approval for the CNSC Reg A offering is an exciting milestone for us as it opens doors for new investors. The capital will help CannAssist’s continued expansion of the brand…

Continue Reading